- Report
- January 2026
- 180 Pages
Global
From €4055EUR$4,500USD£3,479GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,471GBP
- Report
- August 2026
- 142 Pages
Global
From €4280EUR$4,750USD£3,672GBP
- Report
- January 2026
- 160 Pages
Global
From €2847EUR$3,160USD£2,443GBP
€3559EUR$3,950USD£3,054GBP
- Report
- September 2026
- 186 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- May 2026
- 400 Pages
Global
From €4459EUR$4,949USD£3,826GBP
- Report
- July 2026
- 509 Pages
Global
From €5248EUR$6,028USD£4,350GBP
- Report
- February 2026
- 141 Pages
Global
From €2702EUR$2,999USD£2,318GBP
€3603EUR$3,999USD£3,091GBP
- Report
- January 2026
- 185 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- January 2026
- 197 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 198 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 185 Pages
Global
From €3194EUR$3,545USD£2,740GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 191 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 194 Pages
Global
From €3194EUR$3,545USD£2,740GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 193 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- January 2026
- 191 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,471GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,471GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,471GBP
- Report
- August 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,471GBP

Autologous cell therapy is a type of regenerative medicine that uses a patient's own cells to treat a variety of diseases and conditions. It is a form of personalized medicine that is based on the patient's own genetic makeup. Autologous cell therapy is used to treat a variety of conditions, including cancer, autoimmune diseases, and degenerative diseases. Genomics plays an important role in autologous cell therapy, as it allows for the identification of the patient's own cells and the selection of the most appropriate cells for the therapy. Genomics also helps to identify the best treatment strategy for the patient, as well as to monitor the progress of the therapy.
Some companies in the autologous cell therapy market include Celgene, Novartis, and Kite Pharma. Show Less Read more